Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Despite Earnings Miss, Our Liquid Biopsy Play Gets the Good Housekeeping "Seal of Approval"

There's an old adage in business that I know you're familiar with: "You have to spend money to make money."

And after looking at the second-quarter earnings report of our "Liquid Biopsy" play, Trovagene Inc. (Nasdaq: TROV), that's exactly the force at work here.

The small-cap biotech firm reported a loss that was bigger than expected, and that sent shares down nearly 8% today.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK